In fact, NF1 loss-of-function mutations frequently co-occur with BRAF non-V600 class II mutations; in fact, melanomas harboring BRAF III non-V600 mutations have frequently co-occurring NF1 loss-of-function mutations (67%) and RAS mutations (22%). The gene discussed is BRAF; the disease is melanoma.